BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1812289)

  • 1. Cellular components of proliferative vitreoretinal membranes.
    Kwak SI; Chung H; Lee J
    Korean J Ophthalmol; 1991 Dec; 5(2):68-75. PubMed ID: 1812289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M; Esser P; Wiedemann P; Heimann K
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases.
    Heidenkummer HP; Kampik A; Petrovski B
    Retina; 1992; 12(1):52-8. PubMed ID: 1565872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG; Brem RB; Wilson DJ; O'Rourke LM; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
    Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subretinal membranes in proliferative vitreoretinopathy. An immunohistochemical study.
    García-Arumí J; Corcostegui B; Tallada N
    Retina; 1992; 12(3 Suppl):S55-9. PubMed ID: 1280852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cells in culture of preretinal membrane of proliferative vitreoretinopathy.
    Yamashita H; Hori S; Kitano S; Ishii Y; Masuda K
    Jpn J Ophthalmol; 1985; 29(1):42-53. PubMed ID: 3892106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
    Heidenkummer HP; Kampik A
    Ger J Ophthalmol; 1992; 1(3-4):170-5. PubMed ID: 1483131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
    Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological study on the intraocular proliferative membrane of proliferative diabetic retinopathy and proliferative vitreoretinopathy].
    Aoyama R
    Nippon Ganka Gakkai Zasshi; 1990 Apr; 94(4):383-93. PubMed ID: 2396589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP; Kampik A
    Fortschr Ophthalmol; 1991; 88(3):219-24. PubMed ID: 1889766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contractile elements in proliferative retinal diseases].
    Molitor R; Esser P; Weller M; Wiedemann P; Heimann K
    Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
    Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ
    Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Augustin AJ; Spitznas M; Koch F; Grus F; Böker T
    Ger J Ophthalmol; 1995 Jan; 4(1):47-51. PubMed ID: 7728110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens and lymphocytes in proliferative vitreoretinopathy.
    Proença R; Carvalho M; Proença D; Verissimo J; Regadas I; Travassos A
    Graefes Arch Clin Exp Ophthalmol; 1994 Jan; 232(1):25-32. PubMed ID: 8119598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy.
    Baudouin C; Fredj-Reygrobellet D; Brignole F; Nègre F; Lapalus P; Gastaud P
    Ophthalmic Res; 1993; 25(1):52-9. PubMed ID: 8446368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.